Opioid addiction at an all time high

Vitamin D could halve the risk of severe asthma attacks

According to a recent reports by state level narcotics departments, Opioid addiction and opioid deaths have reached epidemic levels across the nation, but a concrete treatment for this is nowhere in sight.

The root of ever increasing opioid addiction is the number of prescriptions being handed out. About a third of the patients prescribed opioid for non-cancer related pain will become addicted. Just like any other addiction, even to the nicotine in tobacco or to alcohol, opioids actually change the chemistry and structure of the brain to create a powerful drive to consume more and more.

These changes in the brain make it hard to treat someone with an addiction, especially to opioids. Addiction is a disease, not a moral failing. The neurotransmitter dopamine drives all our most powerful cravings, and the dopamine rush that accompanies using these drugs or other addictive products overwhelms even our normal survival instincts. Addicts can relapse, sometimes hours after checking out of rehab. Our brains can actually become the driver for repetitive behavior that can kill us.

Marijuana use may not aid patients in opioid addiction treatment

Many patients who are being treated for opioid addiction in a medication-assisted treatment clinic use marijuana to help manage their pain and mood symptoms.

But new research led by Marian Wilson, Ph.D., of the Washington State University College of Nursing found that frequent marijuana use seems to strengthen the relationship between pain and depression and anxiety, not ease it.

“For people who are using cannabis the most, they have a very strong relationship between pain and mood symptoms, and that’s not necessarily the pattern you’d want to see,” Wilson said. “You would hope, if cannabis is helpful, the more they use it the fewer symptoms they’d see.”

The research, recently published in the journal Addictive Behaviors, involved 150 patients being seen at an opioid treatment clinic. Previous studies have shown that nearly two-thirds of patients receiving medication-assisted treatment for opioid addiction also have chronic pain, and many experience depression and anxiety.

About 67 percent of the clinic patients surveyed by Wilson and her team said they had used marijuana in the past month.

“Some are admitting they use it just for recreation purposes, but a large number are saying they use it to help with pain, sleep, and their mood,” Wilson said. “We don’t have evidence with this study that cannabis is helping with those issues.” In fact, the relationship between pain and depression and anxiety increased with the frequency of marijuana use.

In most cases, people reported they were self-medicating with marijuana, Wilson noted, yet only a small number had a medical marijuana card.

The study noted that opioid overdose rates have more than tripled in the past two decades and are now the second-leading cause of accidental death in the United States. There are many questions about the relationship between marijuana use and opioid addiction and treatment – such as why opioid death rates are 25 percent lower in states that have legalized medical marijuana – but the primary purpose of Wilson’s study was to see whether cannabis use affects the relationship between pain and depression and anxiety.

Patients believe using marijuana helps them with their symptoms, but the study’s results could indicate the opposite is true for those in addiction treatment – that by strengthening the connection between feelings of pain and emotional distress, it makes it harder for them to manage their symptoms.

“The effectiveness of cannabis for relieving distressing symptoms remains mixed and requires further research,” the study concludes.

Previous articleOldest ever black hole discovered by astronomers
Next article3D printing with live organisms is a reality now [Video]
Gabriel Scott
With a first-class degree in Chemistry, a PhD in Biochemistry and years of experience working and writing in the pharmaceutical industry, I have the knowledge and understanding to write on a wide range of scientific topics.  I have worked for large pharmaceutical companies and small agencies in both regulatory and marketing roles. I have the expertise to deliver a wide range of projects and the experience to understand the quality of work required.


Please enter your comment!
Please enter your name here